QTc dispersion in patients referred for electroconvulsive therapy

Area of Science:

• Cardiology
• Psychiatry
• Clinical Neurophysiology

Background:

• Electroconvulsive therapy (ECT) can induce significant cardiovascular changes.
• Assessing risk factors for arrhythmias during ECT is crucial for patient safety.
• QTc dispersion is a potential marker for cardiac electrical instability.

Purpose of the Study:

• To investigate QTc dispersion as a predictor of arrhythmias in patients undergoing ECT.
• To identify potential risk factors, including cardiac conditions and psychotropic medications, associated with QTc dispersion before ECT.

Main Methods:

• Electrocardiograms (ECGs) from 105 patients prior to ECT were analyzed.
• QTc dispersion was calculated and correlated with patient demographics, cardiac history, and psychotropic drug use.
• Analysis included assessment of atypical antipsychotics and other psychotropic medication classes.

Main Results:

• No significant association was found between QTc dispersion and patient age or sex.
• The presence of cardiac illness did not correlate with prolonged QTc dispersion.
• None of the studied psychotropic medication classes, including atypical antipsychotics, were associated with increased QTc dispersion.

Conclusions:

• Baseline QTc dispersion does not appear to be a reliable indicator of arrhythmia risk in patients undergoing ECT.
• Cardiac illness and common psychotropic medications do not seem to influence baseline QTc dispersion in this population.
• Further research may be needed to identify specific predictors of ECT-induced arrhythmias.